Spots Global Cancer Trial Database for locally advanced or metastatic, unresectable soft tissue sarcoma
Every month we try and update this database with for locally advanced or metastatic, unresectable soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | NCT00626704 | Locally Advance... Sarcoma Soft Tissue Sar... | AMG 655 Placebo Doxorubicin | 18 Years - | Amgen | |
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | NCT00626704 | Locally Advance... Sarcoma Soft Tissue Sar... | AMG 655 Placebo Doxorubicin | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
